"Allosteric regulation" of calcium-uptake in rat liver mitochondria

During investigations of calcium uptake by rat liver mitochondria, at a buffered free calcium concentration of 2 microM, a considerable acceleration of calcium uptake was occasionally observed. From the following experiments it can be concluded that the acceleration occurred when mitochondria had become anaerobic, and hence deenergized, because they had been stored in the refrigerator for a while. Mitochondria which had become transitorily deenergized by blocking the respiratory chain with KCN, rotenone or antimycin showed an accelerated calcium uptake when the membrane potential necessary for calcium uptake was regenerated. This acceleration of calcium uptake was also seen when a potassium diffusion potential was induced by valinomycin in previously deenergized mitochondria. The velocity of calcium uptake in transitorily deenergized mitochondria increased irrespective of the presence of magnesium in the incubation medium. The activation of the Ca uniporter was reversible, and both processes, activation and deactivation, were time-dependent and developed within a time span of minutes. Oligomycin strongly inhibited the deactivation of the uniporter by ATP, hence the membrane potential is intrinsically effective and does not act via ATP. The altered kinetics of the Ca uniporter were responsible for the acceleration of calcium uptake which was measured at low calcium concentration with previously deenergized mitochondria. The dependence of the rate of calcium uptake on the concentration of calcium in the medium is hyperbolic in transitorily deenergized mitochondria [Km = 6.7 microM; V = 455 nmol/(min X mg protein)] and sigmoidal in normal ones. It is additionally independent of the presence of magnesium ions. We found Hill coefficients of 3.47 and 2.94 in experiments with and without magnesium, respectively. Correspondent kinetics, hyperbolic in deenergized and sigmoidal in normal mitochondria, were obtained when calcium uptake was not driven by the system of respiratory chain, but by the potassium diffusion potential induced by valinomycin. The alteration in the kinetics of the Ca uniporter has consequences in the range of physiological calcium levels, but mainly in pathological states of liver cells. These points are discussed.     

GABAergic neurosteroids: the "endogenous benzodiazepines" of acute liver failure

Acute liver failure (ALF) or fulminant hepatic failure represents a serious life-threatening condition. ALF is characterized by a significant liver injury that leads to a rapid onset of hepatic encephalopathy (HE). In ALF, patients manifest rapid deterioration in consciousness leading to hepatic coma together with an onset of brain edema which induces high intracranial pressure that frequently leads to herniation and death. It is well accepted that hyperammonemia is a cardinal, but not the sole, mediator in the pathophysiology of ALF. There is increasing evidence that neurosteroids, including the parent neurosteroid pregnenolone, and the progesterone metabolites tetrahydroprogesterone (allopregnanolone) and tetrahydrodeoxycorticosterone (THDOC) accumulate in brain in experimental models of ALF. Neurosteroids in ALF represent good candidates to explain the phenomenon of "increased GABAergic tone" in chronic and ALF, and the beneficial effects of benzodiazepine drugs. The mechanisms that trigger brain neurosteroid changes in ALF are not yet well known, but could involve partially de novo neurosteroidogenesis following activation of the translocator protein (TSPO). The factors that contribute to TSPO changes in ALF may include ammonia and cytokines. It is possible that increases in brain levels of neurosteroids in ALF may result in auto-regulatory mechanisms where hypothermia may play a significant role. Possible mechanisms that may involve neurosteroids in the pathophysiology of HE, and more speculatively in brain edema, and inflammatory processes in ALF are suggested.     

Apc tumor suppressor gene is the "zonation-keeper" of mouse liver

The molecular mechanisms by which liver genes are differentially expressed along a portocentral axis, allowing for metabolic zonation, are poorly understood. We provide here compelling evidence that the Wnt/beta-catenin pathway plays a key role in liver zonation. First, we show the complementary localization of activated beta-catenin in the perivenous area and the negative regulator Apc in periportal hepatocytes. We then analyzed the immediate consequences of either a liver-inducible Apc disruption or a blockade of Wnt signaling after infection with an adenovirus encoding Dkk1, and we show that Wnt/beta-catenin signaling inversely controls the perivenous and periportal genetic programs. Finally, we show that genes involved in the periportal urea cycle and the perivenous glutamine synthesis systems are critical targets of beta-catenin signaling, and that perturbations to ammonia metabolism are likely responsible for the death of mice with liver-targeted Apc loss. From our results, we propose that Apc is the liver "zonation-keeper" gene.     

Separation of neutral lipids of shark liver by "dry-column" chromatography

"Dry-column" chromatography in mixed solvents has been successfully used to separate gram quantities of neutral lipids from shark liver oil into simpler fractions.     

"In vivo" (35S)methionine interaction with rat liver tRNA

As part of a study to characterize the methionine role in tumorigenesis, we report that methionine sulfur interacts with rat liver tRNA "in vivo" (35S) radioactivity remained associated to the nucleic acid after a number of treatments, including tRNA deacylation. Similar data were obtained after administration of (methyl-3H) methionine, while no comparable tRNA labelling was detected when the aminoacid labelled in the aliphatic chain was given. Hplc analysis of (35S) tRNA enzymic hydrolysate showed two unidentified UV-absorbing radioactive peaks. NMR spectra of these two peaks did not reveal any thiomethyl group.     

Evaluation of the "Cellscreen" system for proliferation studies on liver progenitor cells

Proliferation studies on mammalian cells have been disadvantaged by the limited availability of non-invasive assays as the majority of approaches are based on chemical treatment, sampling or staining of cells removed from culture. In this study, we utilised the Cellscreen system (Innovatis AG, Bielefeld, Germany), a non-invasive automated technique for measuring proliferation of adherent and suspension cells over time. We have evaluated the ability of the Cellscreen system to monitor and quantify growth of adherent liver progenitor cells over time and tested several applications, (i) serum reduction or (ii) treatment with a cytokine. Our results demonstrate that the Cellscreen system reproducibly documents pro- and anti-proliferative effects of cytokines and growth factors and quantifies changes by providing cell-doubling times for control and test cultures. However, we found that for the conversion of cell density values into absolute cell numbers different conversion factors, which better suit the individual growth phases, need to be established. Collectively, these findings reveal that the Cellscreen system is applicable for the determination of cell proliferation of adherent and suspension cells in response to a variety of (growth) factors. It minimises operator participation and thus enables more rapid and larger screens and, being non-invasive, permits multiple assays on the same culture of cells. Hence, this technique proves superior to the common proliferation assays opening up new dimensions of proliferation studies in cell biology.